Derived from Latin, the notion “in vitro diagnostics” refers to tests such as blood, tissues, or urine tests that are carried out in controlled environment outside a living organism. In vitro diagnostics tests are usually held in a laboratory, while sometimes they are carried out at home. In vitro diagnostics is used in hematology, clinical chemistry, molecular diagnostics, immunology, etc.
Development of technologies, the growing incidence of respiratory, sexually transmitted diseases are among the top factors contributing to the market growth. In vitro diagnostics gains popularity worldwide and the market grows swiftly, especially in developing countries such as India and China. Alere Inc, Beckman Coulter Inc and Diasorin Diagnostic S.P.A. are amidst majors are active in the in vitro diagnostics market.
The Catalogue includes research reports offering cutting-edge data on the market for in vitro diagnostics. The reports provide analyses market’s drivers and restraints. The research studies contain profiles of leading market participants. Overviews of the competitive landscape and technologies are available in the reports too.
Publications found:
37,115
Sort by:
LAMEA Molecular Diagnostics Market (2016 - 2022)
US$ 1,500.00
... & infectious diseases and technological advancements is leading the market for molecular diagnostics market in LAMEA. According to the report by Avert in 2016, In Latin America, 1.6 people and In Brazil 830 ... Africa, Nigeria and Rest of LAMEA. The report covers the analysis of key stake holders of the Molecular Diagnostics market. Key companies profiled in the report ...
February 2017
130 pages
North America Molecular Diagnostics Market (2016 - 2022)
US$ 1,500.00
... most effected region is North America. Hence, it could be expected that high prevelance of diseases could result in growth of molecular devices market in North America. The Molecular Diagnostics Market is segmented on the basis of Product & Services, Technology, Application, End-user and Region. Based on Product & Services, the market is segmented ...
February 2017
106 pages
2017 Asia-Pacific Blood Typing, Grouping and Infectious Disease Screening Market: Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies
US$ 11,430.00
... 40 blood typing, grouping and infectious disease screening tests, including NAT assays. Current and Emerging Products Analysis of current and emerging molecular blood typing, grouping and ... blood banking market. Companies developing or marketing new technologies and products, by test. Strategic Recommendations New product development opportunities for molecular blood typing, grouping ...
February 2017
540 pages
2017 Europe Blood Typing, Grouping and Infectious Disease Screening Market: Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies
US$ 26,550.00
... 40 blood typing, grouping and infectious disease screening tests, including NAT assays. Current and Emerging Products Analysis of current and emerging molecular blood typing, grouping and ... blood banking market. Companies developing or marketing new technologies and products, by test. Strategic Recommendations New product development opportunities for molecular blood typing, grouping ...
February 2017
770 pages
2017 Latin America Blood Typing, Grouping and Infectious Disease Screening Market: Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies
US$ 4,905.00
... , MALDI-TOF-MS, Mini-Sequencing Blood Typing and Grouping Tests ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd ... 40 blood typing, grouping and infectious disease screening tests, including NAT assays. Current and Emerging Products Analysis of current and emerging molecular blood typing ...
February 2017
440 pages
2017 Middle East Blood Typing, Grouping and Infectious Disease Screening Market: Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies
US$ 6,120.00
... , MALDI-TOF-MS, Mini-Sequencing Blood Typing and Grouping Tests ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd ... 40 blood typing, grouping and infectious disease screening tests, including NAT assays. Current and Emerging Products Analysis of current and emerging molecular blood typing ...
February 2017
465 pages
2017 North America Blood Typing, Grouping and Infectious Disease Screening Market: Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies
US$ 9,450.00
... , MALDI-TOF-MS, Mini-Sequencing Blood Typing and Grouping Tests ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd ... 40 blood typing, grouping and infectious disease screening tests, including NAT assays. Current and Emerging Products Analysis of current and emerging molecular blood typing ...
February 2017
475 pages
2017-2021 Emerging Opportunities in the Cell Surface Markers: US, Europe (France, Germany, Italy, Spain, UK), Japan--Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 4,815.00
The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both ...
February 2017
120 pages